0       0

28th Annual North American Cystic Fibrosis Conference


S10: NT: Fruit of the Pipeline: The Latest Clinical Trial Data


Oct 10, 2014 10:30am ‐ Oct 10, 2014 12:20pm

Standard: $49.99

Description

This session will address recent clinical trials that test novel approaches to CF therapies directed at overcoming the basic defect of missing or dysfunctional CFTR.

Learning Objectives:
  • Describe approaches, utility and potential barriers to replacing a defective CFTR using gene therapy.
  • Discuss approaches to correcting F508del CFTR and its potential clinical utility.
  • Describe different potential cellular targets & mechanisms for F508del-directly therapies.

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content